Altimmune, Inc.ALTNASDAQ
Loading
Stockholders Equity Over TimeExpanding
Percentile Rank93
3Y CAGR+6.7%
5Y CAGR-0.1%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
+6.7%/yr
vs +39.9%/yr prior
5Y CAGR
-0.1%/yr
Recent acceleration
Acceleration
-33.3pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $224.89M | +82.1% |
| 2024 | $123.51M | -36.4% |
| 2023 | $194.10M | +4.8% |
| 2022 | $185.29M | -7.0% |
| 2021 | $199.13M | -11.8% |
| 2020 | $225.88M | +396.2% |
| 2019 | $45.52M | -5.8% |
| 2018 | $48.31M | -0.7% |
| 2017 | $48.68M | +150.2% |
| 2016 | $19.46M | - |